Axonal growth therapeutics: regeneration or sprouting or plasticity?
- 31 May 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Neurosciences
- Vol. 31 (5), 215-220
- https://doi.org/10.1016/j.tins.2008.02.004
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Molecular dissection of the myelin-associated glycoprotein receptor complex reveals cell type–specific mechanisms for neurite outgrowth inhibitionThe Journal of cell biology, 2007
- Response to Correspondence: Kim et al., “Axon Regeneration in Young Adult Mice Lacking Nogo-A/B.” Neuron 38, 187–199Neuron, 2007
- Functional Axonal Regeneration through Astrocytic Scar Genetically Modified to Digest Chondroitin Sulfate ProteoglycansJournal of Neuroscience, 2007
- The Nogo–Nogo Receptor Pathway Limits a Spectrum of Adult CNS Axonal GrowthJournal of Neuroscience, 2006
- Chondroitinase ABC Promotes Sprouting of Intact and Injured Spinal Systems after Spinal Cord InjuryJournal of Neuroscience, 2006
- Delayed Nogo receptor therapy improves recovery from spinal cord contusionAnnals of Neurology, 2006
- Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?Nature Reviews Neuroscience, 2006
- Extracellular regulators of axonal growth in the adult central nervous systemPhilosophical Transactions B, 2006
- Structural and functional recovery from early monocular deprivation in adult ratsProceedings of the National Academy of Sciences of the United States of America, 2006
- Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cordExperimental Neurology, 2003